IMMUNEONCO-B
015413.0250.83% ( +0.025 )
IMMUNEONCO-B (01541)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc., a biotechnology company, engages in the research and development of immuno-oncology therapies in China and the Un...
- Open
- 2.960
- High
- 3.095
- Low
- 2.925
- Prev. Close
- 3.000
- Volume
- 28.40K
- Turnover
- 85.36K
- Avg Price
- 3.006
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 5.67%
- 52wk High
- 16.800
- Volume Ratio
- 0.13
- Turnover Ratio
- 0.01%
IMMUNEONCO-B Analyst Rating
View MoreForecast & Rating
Jul 10, 2026Price forecast
HK$6.28107.62%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 days ago, 07:18 AM
ImmuneOnco clarifies subsidiary capital increase as employee incentive scheme via ESOP platform
- Global Report · Jul 30 at 04:14 AM
The Tech Giants' AI Rush Is Masking a Severe Fracture in Hong Kong's Market
- PUBT · Jul 24 at 06:03 AM
ImmuneOnco files HKEX next-day disclosure return reporting share repurchase for treasury shares
- PUBT · Jul 23 at 05:28 AM
ImmuneOnco files HKEX next-day disclosure return on share repurchase cancellation
- PUBT · Jul 22 at 04:18 AM
S.F. Holding files HKEX next-day disclosure return on share repurchase for cancellation
- Global Report · Jul 21 at 04:13 AM
Hong Kong Cross-Sector Moves: Key Catalysts for 10 Equities From Biotech to Industrials
